CDK1 and Cyclin A Expression is Linked to Cell Proliferation and Associated with Prognosis in Non-Hodgkin's Lymphomas

References

• Costa A., Bonadonna G., villa E., Valagussa P., Silvestrini R. Labeling index as a prognostic marker in non-Hodgkin's lymphomas. Journal of National Cancer lnstitute. 1981; 66: 1–5
   PubMed Web of Science ®Google Scholar
• Srigley J., Barlogie B., Butler J. J., Osborne B., Blick M., Johnston D., Kantarjian H., Reuben J., Batsakis J., Freire-Ich E. J. Heterogeneity of non-Hodgkin's lymphoma probed by nucleic acid cytometry. Blood 1985; 65: 1090–1096
   PubMed Web of Science ®Google Scholar
• Berger R, Felman P., Sonet A., Salles G., Bastion Y., Bryon P. A., Coiffier B. Nonfollicular small B-cell lymphomas: a heterogenous group of patients with distinct clinical features and outcome. Blood 1994; 83: 2829–2835
   PubMed Web of Science ®Google Scholar
• Silvestrini R., Costa A., Giardini R., Boracchi P., Del Bino G., Marubini E., Rilke F. Prognostic implications of cell kinetics, histopathology and pathologic stage in non-Hodgkin's lymphomas. Hematology- Oncology 1989; 7: 411–422
   PubMed Web of Science ®Google Scholar
• Ffrench M., Magaud J. P., Ffrench P., Berger F., Devaux Y., Duhaut P., Shen N., Coiffier B., Bryon P. A. Heterogeneity of neoplastic and reactive cell proliferation in non-Hodgkin's lymphomas linked to patient survival. American Journal of Clinical Pathology 1994; 101: 413–420
   PubMed Web of Science ®Google Scholar
• Sherr C. J., Mammalian GI. Cell 1993; 73: 1059–1065
   PubMed Web of Science ®Google Scholar
• Draetta G., Beach D. cell cycle-dependent phos-phorylation and subunit rearrangement. Cell 1988; 54: 17–26, Activation of cdc2 protein kinase during mitosis in human cells
   PubMed Web of Science ®Google Scholar
• Lees E., Faha B., Dulic V., Reed S. I., Harlow E. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Develop ment 1992; 6: 1874–1885
   PubMed Web of Science ®Google Scholar
• Pagano M., Pepperkok R., Lukas J., Baldin V., Ansorge W., Bartek J., Draetta G. Regulation of the cell cycle by the cdk2 protein kinase in cultud fibroblasts. Journal of Cell Biology 1993; 121: 101–111
   PubMed Web of Science ®Google Scholar
• Matsushime H., Ewen M. E., Strom D. K., Kato J. Y., Hanks S. K., Rowel M. F., Sherr C. J. Identification and prpeorties of an atypical catalytic subunit (p34PSK-13/cdk4) for mammalian D type G1 cyclins. Cell 1992; 71: 323–334
   PubMed Web of Science ®Google Scholar
• Meyerson M., Harlow E. Identification of GI kinase activity for cdk6, a novel cyclin D partner. Molecular and Cellular Biology 1994; 14: 2077–2086
   PubMed Web of Science ®Google Scholar
• Rimokh R., Berger F., Bastard C., Klein B., Ffrench M., Archimbaud E., Rouault J. P., Santa Lucia B., Duret L., Vuillaume M., Coiffier B., Bryon P. A., Magaud J. P. Rearrangement of CCND1 (BCLIPRADI) 3 untranslated region in Mantle cell lymphomas and t (11q13)-associated leukemias. Blood 1994; 83: 3689–3696
   PubMed Web of Science ®Google Scholar
• Paterlini P., Suberville A. M., Zindy F., Melle J., Sonnier M., Marie J. P., Dreyfus F., Brkhot C. Cyclin A expression in human hematological malignancies: a new marker of cell proliferation. Cancer Research 1993; 53: 235–238
   PubMed Web of Science ®Google Scholar
• Wolowiec D., Deviller P., Simonin D., Souchier C., Rimokh R., Benchaib M., Bryon P. A., Ffrench M. cdkl is a marker of proliferation in human lymphoid cells. International Journal of Cancer 1995; 61: 381–388
   PubMed Web of Science ®Google Scholar
• Gong J., Li X., Traganos F., Darzynkiewicz Z. Expression of G1 and G2 cyclins measured in individual cells by multiparameter flow cytometry: a new tool in the analysis of the cell cycle. Cell Proliferation. 1994; 27: 357–371
   Web of Science ®Google Scholar
• Wotowiec D., Benchaib M., Pernas P., Deviller P., Souchier C., Felman P., Rimokh R., Bryon P. A., Ffrench M. Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue. Leukemia 1995; 9: 1382–1388
   Google Scholar
• National Cancer Institute Sponsored Study of Classifications of Non-Hodgkin's lymphomas. Summary and description of a Working Formulation for Clinical Usage. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• A Revised European-American Classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Coiftier B., Bryon P. A., Ffrench M., Blanc M., Sebban C., Berger F., Viala J. J. Intensive chemotherapy in aggressive lymphomas: update results of LNH-80 protocol and prognostic factors affecting response and survival. Blood 1987; 70: 1394–1399
   PubMed Web of Science ®Google Scholar
• Coiffier B., Gisselbrecht C., Herbrecht R., Tilly H., Bosly A., Browse N. NHL-84 regimen: A multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. Journal of Clinical Oncology 1989; 7: 1018–1026
   PubMed Web of Science ®Google Scholar
• Ffrench M., Bryon P. A., Fière D., Vu van H., Gentil-Home O., Adeleine P., Viala J. J. Cell-cycle, protein content and nuclear size in acute myeloid leukemia. Cytometry 1985; 6: 47–53
   PubMedGoogle Scholar
• Ajchenbaum F., Ando K., DeCaprio J. A., Griffin J. D. Independent regulation of human D-type cyclin gene expression during Gl phase in primary human T lymphocytes. Journal of Biological Chemistry 1993; 268: 4113–4119
   PubMed Web of Science ®Google Scholar
• Tam S. W., Theodoras A. M., Shay J. W., Draetta G., Pagano M. Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with cdk4 is required for cyclin D1 function in G1 progression. Oncogene 1994; 9: 2663–2674
   PubMed Web of Science ®Google Scholar
• Sanchez-Beato M., Saez A. I., Martinez-Montero J. C., Mateo M. S., Sanchez-Verde L., Villuendas R., Troncone G., Piris M. A. Cyclin dependent kinase inhibitor p27pkip in lymphoid tissue. American Journal of Pathology 1997; 151: 151–160
   PubMed Web of Science ®Google Scholar
• Ffrench M., Souchier C., Magaud J. P., Berger F., Devaux Y., Bryon P. A. Cell proliferation in B malignant lymphomas: comparison with other biological characteristics and prognostic significance. Leuk. Lymph. 1992; 6: 231–238
   Web of Science ®Google Scholar
• de Boer C. J., Schuuring E., Dreef E., Peters G., Bartek J., Kluin P. M., van Krieken J. H. J. M. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood 1995; 86: 2715–2723
   PubMed Web of Science ®Google Scholar
• Iversen O. H., Iversen U., Ziegler J. L., Bluming A. Z. Cell kinetics in Burkitt lymphoma. European Journal of Cancer 1974; 10: 155–163
   PubMed Web of Science ®Google Scholar
• Shi L., Nishioka W. K., Th'ng J., Bradbury E. M., Litchfiels D. W., Greenberg A. H. Premature p34cdc2 activation required for apoptosis. Science 1994; 263: 1143–1145
   PubMed Web of Science ®Google Scholar
• Yao S. L., McKenn K. A., Sharkis S. J., Bedi A. Requirement of p34 kinase for apoptosis mediated by the Fas/APO-1 receptor and interleukin 1b˜-converting enzyme-related proteases. Cancer Research 1996; 56: 4551–4555
   PubMed Web of Science ®Google Scholar